Clinical Trial Update: Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of ofatumumab with fludarabine and cyclophosphamide in patients with chronic lymphocytic leukemia; the trial completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Ofatumumab (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphocytic, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2011-10-17